Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Policy Evaluation Counterfactual Impact Evaluation× | Съгласуване по показател на склонност× | |
|---|---|---|
| Област≠ | Причинно-следствено заключение | Статистика за изследвания |
| Семейство≠ | Regression model | Process / pipeline |
| Година на възникване≠ | 1974 (Rubin potential outcomes); 2010s (EU policy CIE formalisation) | 1983 |
| Създател≠ | Rubin (potential outcomes framework); European Commission DG Research formalised policy CIE guidelines | Paul Rosenbaum and Donald Rubin |
| Тип≠ | Quasi-experimental causal evaluation | Method |
| Основополагащ източник≠ | Imbens, G. W., & Rubin, D. B. (2015). Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction. Cambridge University Press. ISBN: 978-0521885881 | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Други названия≠ | CIE, policy CIE, counterfactual policy evaluation, impact evaluation | PSM, propensity score weighting, covariate balance |
| Свързани≠ | 5 | 3 |
| Резюме≠ | Counterfactual Impact Evaluation (CIE) for policy assessment estimates the causal effect of a public policy or programme by comparing observed outcomes of participants against a rigorously constructed counterfactual — what would have happened had the policy not existed. Rooted in the Rubin potential-outcomes framework, CIE is the standard methodology endorsed by the European Commission for evaluating research, innovation, and structural funding programmes. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateНабор от данни ↗ |
|
|